Does veterinary medicine (animal drugs) also need to comply with CPOB criteria?

Yes, animal drug manufacturing must meet CPOB requirements, although the registration process and potentially some specific aspects (like additional elements for herbal ingredients in traditional medicine CPOB vs. standard CPOB) will differ.

Must the person in charge of quality supervision (QC/QA) be a pharmacist, or can it be a pharmaceutical technical personnel?

It is legally required for the person in charge of QC, Production, and Distribution to be a pharmacist.

If an error occurs in a finished drug, will the product be discarded or reprocessed?

It depends on the severity of the defect. Minor defects (minor errors like slightly crooked printing) can usually be reprocessed, but critical defects that impact efficacy or safety must be recalled and destroyed.

What is the difference between Management Quality (2012) and Quality System (2018) regarding control?

Management Quality typically requires supervision and planning, whereas a Quality System implies that good practices have become an ingrained habit (a habit that becomes second nature) for all stakeholders.

Are Class A cleanrooms only necessary in production areas, or also in QC labs?

Class A cleanrooms are required wherever sterility is critical, which includes not only aseptic processing rooms in production but also in the Quality Control (QC) microbiology laboratory for sterility testing.

What is the difference between a Pass Box and a Pass Through (Passro)?

A Pass Box is used when transferring materials between rooms of the *same* cleanroom classification (e.g., Class B to Class B) and does not require complex air interlocking systems. A Pass Through (Passro) is mandatory when transferring materials between rooms of *different* classifications (e.g., cleaner to dirtier area) and must incorporate air control systems to maintain differential pressure and particle counts.

Kuliah pakar Prodi DIII Farmasi STIKes Karsa Husada Garut oleh Dr. TPH. Simorangkir (CPOB)

Fundamental Concepts in Pharmaceutical Industry
📌 The essential components for building a pharmaceutical facility include hardware (buildings, equipment, tools), software (guidelines, regulations like CPob), and brainware (personnel, including pharmaceutical and technical staff).
👩‍🔬 The primary roles and functions for pharmaceutical/technical staff are in Production, Quality Control (QC), and Quality Assurance (QA).
⚙️ Production involves processing and packaging, while QC handles sampling, testing, specification, inspection, and monitoring.

CPob (Good Manufacturing Practices) as a Guideline
🧭 The ultimate goal of understanding CPob is to consistently produce high-quality medicine (Safe, Acceptable, Efficacious - SAE).
💡 CPob acts as a compass guiding operations, structured around the core principles: Elimination (E), Validation (V), and Documentation (D).
🚫 Elimination focuses on minimizing errors, weaknesses, and contaminants related to the 12 aspects of CPob (e.g., personnel, facilities, equipment).

Core Responsibilities and Industry Structure
📈 Pharmaceutical quality requires balancing economic aspects (profit margin) with social aspects (sustainability of drug supply).
🔬 Key areas for pharmaceutical technical staff include supervisory roles in Production (sterile/non-sterile), QC, and QA, as well as planning and procurement.
🏢 Pharmaceutical facility design mandates strict separation for sensitive categories like beta-lactams/cephalosporins, hormonal drugs, chemotherapy agents, and biological liquids (e.g., vaccines) to prevent cross-contamination.

Key Points & Insights
➡️ Pharmaceutical quality assurance (QA) requires personnel to have comprehensive knowledge of Production and QC, often needing a minimum of three years experience in these areas before becoming a QA Manager.
➡️ The concept of System Quality (in 2018 guidelines) is preferred over Management Quality, shifting focus from constant supervision to ingrained good habits across all stakeholders.
➡️ Drug quality must be proven, not just declared; QC sampling is representative and not 100% exhaustive, reinforcing the need for robust process validation (V&D).
➡️ For final drug products, critical defects (e.g., pharmacological impact like the Bupivacaine incident) necessitate recall and destruction, whereas minor defects might allow for reprocessing.

📸 Video summarized with SummaryTube.com on Feb 10, 2026, 12:10 UTC

Kuliah pakar Prodi DIII Farmasi STIKes Karsa Husada Garut oleh Dr. TPH. Simorangkir (CPOB)

Loading Similar Videos...

Recently Summarized Videos

📜Transcript

📄Video Description

Loading Similar Videos...

Recently Summarized Videos

💎Related Tags

Get the Chrome Extension